CBLC antibody
Quick Overview for CBLC antibody (ABIN7112417)
Target
See all CBLC AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- CBLC antibody
-
Purification
- Immunogen affinity purified
-
Purity
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- Cas-Br-M(murine) ecotropic retroviral transforming sequence c
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:500-1:2000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze / thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- -20°C for 12 months
-
Expiry Date
- 12 months
-
-
- CBLC (Cbl proto-oncogene C (CBLC))
-
Alternative Name
- CBLC
-
Background
-
Synonyms: E3 ubiquitin-protein ligase CBL-C|RING finger protein 57|RING-type E3 ubiquitin transferase CBL-C|SH3-binding protein CBL-3|SH3-binding protein CBL-C|Signal transduction protein CBL-C|CBLC|CBL3|RNF57
Background: Acts as an E3 ubiquitin-protein ligase, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and then transfers it to substrates promoting their degradation by the proteasome. Functionally coupled with the E2 ubiquitin-protein ligases UB2D1, UB2D2 and UB2D3. Regulator of EGFR mediated signal transduction, upon EGF activation, ubiquitinates EGFR. Isoform 1, but not isoform 2, inhibits EGF stimulated MAPK1 activation. Promotes ubiquitination of SRC phosphorylated at 'Tyr-419'. In collaboration with CD2AP may act as regulatory checkpoint for Ret signaling by modulating the rate of RET degradation after ligand activation, CD2AP converts it from an inhibitor to a promoter of RET degradation, the function limits the potency of GDNF on neuronal survival.
-
Molecular Weight
- 52 kDa
-
Gene ID
- 23624
-
UniProt
- Q9ULV8
-
Pathways
- EGFR Signaling Pathway
Target
-